Missouri Clinical Trials

A listing of Missouri clinical trials actively recruiting patient volunteers.

“The Show Me State,” Missouri shares the Kansas City Metro Area with its neighbor Kansas. Its other major metroplex, on the opposite side of the state, is St. Louis, followed by Springfield and Columbia. The 18th most populous state and 21st biggest by area, virtually all major routes used during the westward expansion of the U.S. started here – including the famous Oregon Trail. You won’t have to journey across mountains and over rivers to find superb healthcare: The largest providers are centered around St. Louis, with Barnes Jewish Hospital operating as the teaching hospital for Washington University School of Medicine.

Filter by Condition
2027 trials found

Characterization of Product Use in Smokers Switching From Cigarettes to a RELX Electronic Nicotine Delivery System

NCT04708106

The study will assess product use behaviors, biomarkers of exposure, subjective effects, and safety in smokers who switch to a RELX ENDS over 8-weeks.

Conditions: Electronic Cigarette Use
Phase: Not Applicable

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

NCT04702243

The investigators will utilize a systematic approach for the diagnostic evaluation of patients to identify characteristics which may distinguish between Primary Immunodeficiency (PID) disorders versus Primary Ciliary Dyskinesia (PCD).

Conditions: Primary Ciliary Dyskinesia, Primary Immune Deficiency, Kartagener Syndrome

Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

NCT04701983

Primary Objective: Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPD Secondary Objectives: Evaluate the efficacy of itepekimab compared with placebo on pulmonary function in former smokers with moderate-to-severe COPD Evaluate the efficacy of itepekimab compared with placebo on occurrence of acute exacerbation of COPD (AECOPD) in former smokers with moderate-to-severe C ...

Conditions: Chronic Obstructive Pulmonary Disease

Compassionate Use of Domperidone for Refractory Gastroparesis

NCT04699591

The purpose of this program is to allow the use of domperidone in children from 12 to 21 years of age with symptoms related to motility disorders and Gastroesophageal reflux disease (GERD) who have failed all the standard treatments for their condition.

Conditions: GERD, Gastroesophageal Reflux, Gastroparesis
Phase: Not Applicable

A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)

NCT04700449

This study will evaluate the efficacy and safety of CBP-307 in subjects with moderate to severe ulcerative colitis (UC).

Conditions: Moderate to Severe Ulcerative Colitis

Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT

NCT04685798

The investigators propose a longitudinal study evaluating post-treatment changes in patients with squamous cell carcinoma (SCC) of the neck using an innovative optimized diffusion-weighted imaging (DWI) pulse sequence to identify more accurately recurrent tumors as well as early non-responders to therapy.

Conditions: Squamous Cell Carcinoma
Phase: Not Applicable

Cardiac Markers in Depressed Patients With Coronary Heart Disease

NCT04682769

Depression doubles the risk of death in patients with coronary heart disease (CHD), but so far, there is insufficient evidence that we can reduce the risk of death by treating depression. This study will investigate the cardiac risk markers that are associated with depression symptoms that remain despite treatment, and identify potential targets for their treatment. The results of the study will inform the development of more effective interventions to improve both depression and survival in pat ...

Conditions: Coronary Heart Disease, Depression

Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors

NCT04680416

T Cell Receptor-engineered T-cell therapy (TCR T-cell therapy) offers a potentially transformative approach to treating cancer, but is currently limited by the lack of known targets (Maus and June, 2016; Ping et al., 2018). Arguably the most clinically meaningful way to discover new targets and TCRs for TCR T-cell therapy is to study the tumorinfiltrating lymphocytes of patients that are actively responding to immune checkpoint inhibitor (ICI) therapy. These T cells are clonally expanded as a re ...

Conditions: Renal Clear Cell Carcinoma

Feasibility Testing of Cognitive Strategy Training in Post-Concussive Syndrome

NCT04681742

This study will evaluate the practicality (i.e. acceptability to stakeholders; outcome battery feasibility; recruitment, retention, and adherence rates) and the preliminary effect of a cognitive strategy training intervention in adults with post-concussive syndrome.

Conditions: Brain Concussion, Post-Concussion Syndrome
Phase: Not Applicable

Treatment of Angiotensin Converting Enzyme Inhibitor-induced Angioedema

NCT04679311

Angiotensin Converting Enzyme (ACE) inhibitors are among the most important and widely prescribed drugs. They reduce the morbidity and mortality associated with high blood pressure, heart disease, and kidney disease. Unfortunately, their use carries the risk of causing life-threatening airway swelling in some patients. There is currently no treatment for this condition. A novel treatment approach that may reduce or completely reverse the swelling will be tested.

Conditions: Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor

Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

NCT04678206

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 2b adaptive dose-finding study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Conditions: Refractory Chronic Cough

DreamKit Diagnostic Validation

NCT04671342

This study has been developed in order to demonstrate diagnostic efficacy of the DreamKit device against polysomnography.

Conditions: Sleep Apnea, Obstructive, Sleep Apnea, Central
Phase: Not Applicable